abstract |
The present invention relates to novel pyrazolopyrimidines and their use as metabotropic glutamate receptor antagonists (mGlu5 receptor antagonists), pharmaceutical compositions containing them, and to treat or ameliorate mGlu5 receptor mediated disorders On how to use it as a drug. |